Domatinostat

DB17521InvestigationalSmall molecule

Domatinostat: Overview.

Chemical structure of Domatinostat
Formula / weight
C23H21N5O3S · 447.51 g/mol (avg)
Also known as
(e)-n-(2-aminophenyl)-3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfonyl)-1h-pyrrol-3-yl)acrylamide · 2-propenamide, n-(2-aminophenyl)-3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfonyl)-1h-pyrrol-3-yl)-, (2e)- · Hdac inhibitor 4sc-202
Code names
4SC-202

Resolves to

Compound
UNII264ARM7UXXCAS910462-43-0ChEMBLCHEMBL4283683
Structure
InChIKeyPRXXYMVLYKJITB-IZZDOVSWSA-NSMILESCN1C=C(C=N1)C1=CC=C(C=C1)S(=O)(=O)N1C=CC(\C=C\C(=O)NC2=CC=CC=C2N)=C1
Targets
Q13547HDAC1

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Domatinostat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In